Company Encyclopedia
View More
name
Proshares UltraShort Nasdaq Biotech
BIS.US
News
View More

Dr. Pejman Ghanouni from Stanford Medicine wins RSNA’s Cum Laude Award for CAPTAIN trial on robotic radical prostatectomy, the first successful recruitment trial in its kind.

Dr. Pejman Ghanouni from Stanford Medicine wins RSNA’s Cum Laude Award for the CAPTAIN trial, which successfully recruited participants to compare a novel technology with standard robotic radical prostatectomy. This trial marks a significant advancement in medical research, highlighting the importance of scientific investigation in improving patient care.

Unusual Whales·
Unusual Whales·

ALS Association pledges $2 million for early-stage clinical trials of 2 new ALS therapies. Accelerating new treatments.

The ALS Association has recently announced the recipients of its 2025 Hoffman ALS Clinical Trial Awards Program in Arlington, Virginia on December 4th. This funding, intended to hasten the advancement of new treatments for ALS, was granted to several individuals. The specific amount awarded was not disclosed, but it is part of the Association's ongoing efforts to support innovative research in ALS treatment.

Unusual Whales·
Unusual Whales·

EXPLAINER-Why are hepatitis B vaccines given to newborns?

Vaccine advisers to U.S. Health Secretary Robert F. Kennedy Jr. will vote on whether to change the hepatitis B vaccine recommendation for children, potentially leaving the decision to parents. The current policy recommends universal vaccination for newborns to prevent HBV transmission, especially from mothers to infants. The vaccine is considered safe, with mild side effects. The change would mark a significant shift in U.S. immunization policy.

Reuters·
Reuters·

Health Rounds: Experimental drug shows promise for stroke patients who miss the current medical treatment window

An experimental drug, scp776, shows promise for stroke patients who miss the treatment window, offering clinically meaningful improvements. Developed by Silver Creek Pharmaceuticals, it inhibits apoptosis and activates repair pathways. The drug has FDA Fast Track designation. Additionally, AI software improves fetal heart defect screening, increasing detection rates and reducing reading time, according to a study using BrightHeart's tool. These advancements highlight significant progress in medical treatments and diagnostics.

Reuters·
Reuters·

IntelePeer Expands Clinical-Grade Agentic Voice AI to Radiology, Delivering Higher Utilization, Lower No-Shows, and Measurable Financial Impact

IntelePeer expands its clinical-grade agentic voice AI to radiology, enhancing patient access, reducing no-shows, and improving financial outcomes. The AI automates patient interactions, from scheduling to billing, with clinical-grade safety and reliability. Success stories include reduced scheduling time and increased patient satisfaction. IntelePeer's solutions are designed for regulated healthcare environments, ensuring compliance and security. The expansion aims to transform patient journeys and operational growth in radiology practices.

fidelity·
fidelity·
© 2025 Longbridge｜Disclaimer